Exelixis Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
All right. Good afternoon, good evening, everybody, on the webcast. Thanks so much for joining us at the BofA Global Healthcare Conference. I am pleased to be introducing the next company presenter, Exelixis, and CEO, Mike Morrissey.
Exelixis is a commercial stage oncology company with an expanding pipeline in the area of oncology. So a lot to talk about as it pertains to Exelixis' lead asset, CABOMETYX, but also the pipeline build out and some of the behind-the-scene strategic efforts to help diversify the company away from CABOMETYX. So first off, Mike, thanks for joining us today.
Jason, great to see you again. Hope you're doing well.
Doing great, doing great.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
